Is Oryzon Genomics S.A. (ORY.MC) a Buy, Sell, or Hold?
BME : ORY.MC
Oryzon Genomics S.A.
$2.958 EUR
-$0.02 (-0.6%)
- Volume
- 131.53K
- Average Volume
- 443.63K
- Market Capitalization
- $242.43M
- P/E Ratio
- -106.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.02
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.83
Company Overview
BME
Carlos Buesa
Biotechnology
Healthcare
ORY.MC
46
ES
EUR
Liquidity Metrics
0.07
1.83
1.83
1.73
0.00
Sales & Valuation
-$
57.45
2.20
0.00
0.00
Profitability
-$0.035
-$2.61M
-51.67%
-130.24%
-2.03%
-1.54%
P/E Metrics
-106.40
-1.33
-1.33
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
5.96
3/9
$10.66M
$141.7M
$23.41M
-$6.68M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Carlos Manuel Buesa Arjol | Co-Founder, Chairman, Chief Executive Officer & President |
| Rolando Gutierrez-Esteinou | Chief Medical Officer for CNS Programs |
| Augusto Pinel Rubio | Secretary |
| Emili Torrell Cortada | Director of Business Development |
| Jordi Xaus Pey | Scientific Director |
| Neus Virgili Bernado | Director of Industrial Property |
| Sonia Paloma Gutierrez Bezon | Director of Clinical Operations |
| Enric Rello Condomines | Chief Operating Officer & Chief Financial Officer |
| Xavier Perpinya Ribera | Head of Internal Audit & Compliance |
Poll Results
No votes yet today — be the first to share your view!
About Oryzon Genomics S.A. (BME:ORY.MC) Stock
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic latera ... l sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Frequently Asked Questions
-
What is the current Oryzon Genomics S.A. (ORY.MC) stock price?
-
Oryzon Genomics S.A.(BME:ORY.MC) stock price is $2.958 in the last trading session. During the trading session, ORY.MC stock reached the peak price of $4.02 while $2.555 was the lowest point it dropped to. The percentage change in ORY.MC stock occurred in the recent session was --0.6% while the dollar amount for the price change in ORY.MC stock was -$0.02.
-
ORY.MC's industry and sector of operation?
-
The BME listed ORY.MC is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ORY.MC?
-
Carlos Manuel Buesa Arjol | Co-Founder, Chairman, Chief Executive Officer & President
Rolando Gutierrez-Esteinou | Chief Medical Officer for CNS Programs
Augusto Pinel Rubio | Secretary
Emili Torrell Cortada | Director of Business Development
Jordi Xaus Pey | Scientific Director -
How many employees does ORY.MC have?
-
Number of ORY.MC employees currently stands at 46. ORY.MC operates from Sant Ferran 74, Cornellà de Llobregat, None 08940, ES.
-
Link for ORY.MC official website?
-
Official Website of ORY.MC is: https://www.oryzon.com
-
How do I contact ORY.MC?
-
ORY.MC could be contacted at phone #34 93 515 13 13 and can also be accessed through its website. ORY.MC operates from Sant Ferran 74, Cornellà de Llobregat, None 08940, ES.
-
How many shares of ORY.MC are traded daily?
-
The average number of ORY.MC shares traded daily for last 3 months was 443.63K.
-
What is the market cap of ORY.MC currently?
-
The market value of ORY.MC currently stands at $242.43M with its latest stock price at $2.958